Screener
Oric Pharmaceuticals, Inc. ORIC Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 39,619 | 32,718 |
| Loss from operations | (39,619) | (32,718) |
| Other income, net | 3,852 | 2,697 |
| Net loss | $(35,767) | $(30,021) |
| Other comprehensive loss: | ||
| Unrealized loss on investments | (1,076) | (170) |
| Comprehensive loss | $(36,843) | $(30,191) |
| Net loss per share, basic and diluted | $(0.34) | $(0.42) |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s net income?
- Oric Pharmaceuticals, Inc. (ORIC) reported net income of -$35.77M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s net income changed year-over-year?
- Oric Pharmaceuticals, Inc.'s net income decreased by 19.1% year-over-year, from -$30.02M to -$35.77M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s net income?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s net income has grown at a 13.2% compound annual growth rate (CAGR), from -$78.72M to -$129.47M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Oric Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude